Treatment decisions and employment of breast cancer patients: Results of a population‐based survey. Issue 24 (9th October 2017)

• Record Type: Journal Article
• Authors: Jagsi, Reshma; Abrahamse, Paul H.; Lee, Kamaria L.; Wallner, Lauren P.; Janz, Nancy K.; Hamilton, Ann S.; Ward, Kevin C.; Morrow, Monica; Kurian, Allison W.; Friese, Christopher R.; Hawley, Sarah T.; Katz, Steven J.
• Is Part Of: Cancer. Volume 123:Issue 24(2017)
• Page Start: 4791
• Page End: 4799
• Publication Date: 2017-10-09
• Subjects: breast cancer -- chemotherapy -- employment -- job -- mastectomy -- work; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.30959
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : BACKGROUND: Many patients with breast cancer work for pay at the time of their diagnosis, and the treatment plan may threaten their livelihood. Understanding work experiences in a contemporary population‐based sample is necessary to inform initiatives to reduce the burden of cancer care. METHODS: Women who were 20 to 79 years old and had been diagnosed with stage 0 to II breast cancer, as reported to the Georgia and Los Angeles Surveillance, Epidemiology, and End Results registries in 2014‐2015, were surveyed. Of the 3672 eligible women, 2502 responded (68%); 1006 who reported working before their diagnosis were analyzed. Multivariate models evaluated correlates of missing work for >1 month and stopping work altogether versus missing work for ≤1 month. RESULTS: In this diverse sample, most patients (62%) underwent lumpectomy; 16% underwent unilateral mastectomy (8% with reconstruction); and 23% underwent bilateral mastectomy (19% with reconstruction). One‐third (33%) received chemotherapy. Most (84%) worked full‐time before their diagnosis; however, only 50% had paid sick leave, 39% had disability benefits, and 38% had flexible work schedules. Surgical treatment was strongly correlated with missing >1 month of work (odds ratio [OR] for bilateral mastectomy with reconstruction vs lumpectomy, 7.8) and with stopping work altogether (OR for bilateral mastectomy with reconstruction vs lumpectomy, 3.1). Chemotherapy receipt (OR for missing >1 month, 1.3; OR for stopping work altogether, 3.9) and race (OR for missing >1 month for blacks vs whites, 2.0; OR for stopping work altogether for blacks vs whites, 1.7) also correlated. Those with paid sick leave were less likely to stop working (OR, 0.5), as were those with flexible schedules (OR, 0.3). CONCLUSIONS: Working patients who received more aggressive treatments were more likely to experience substantial employment disruptions. Cancer 2017;123:4791‐9 . © 2017 American Cancer Society . Abstract : Working patients with early‐stage breast cancer who receive more aggressive treatments are more likely to experience substantial employment disruptions. Information regarding the impact of treatment decisions on employment is relevant for patient decision making.